𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Elevated sclerostin levels in individuals with high bone mass

✍ Scribed by C. Gregson; K. Poole; S. Steel; J. Ayuk; E. McCloskey; W. Fraser; J. Tobias

Book ID
116324224
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
135 KB
Volume
48
Category
Article
ISSN
8756-3282

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Levels of serotonin, sclerostin, bone tu
Levels of serotonin, sclerostin, bone turnover markers as well as bone density and microarchitecture in patients with high-bone-mass phenotype due to a mutation in Lrp5
✍ Morten Frost; Tom Andersen; Fatma Gossiel; Stinus Hansen; Jens Bollerslev; Wim v πŸ“‚ Article πŸ“… 2011 πŸ› American Society for Bone and Mineral Research 🌐 English βš– 216 KB πŸ‘ 1 views

## Abstract Patients with an activation mutation of the __Lrp5__ gene exhibit high bone mass (HBM). Limited information is available regarding compartment‐specific changes in bone. The relationship between the phenotype and serum serotonin is not well documented. To evaluate bone, serotonin, and bo

Relation of age, gender, and bone mass t
Relation of age, gender, and bone mass to circulating sclerostin levels in women and men
✍ Ulrike I MΓΆdder; Kelley A Hoey; Shreyasee Amin; Louise K McCready; Sara J Achenb πŸ“‚ Article πŸ“… 2011 πŸ› American Society for Bone and Mineral Research 🌐 English βš– 278 KB πŸ‘ 2 views

Sclerostin is a potent inhibitor of Wnt signaling and bone formation. However, there is currently no information on the relation of circulating sclerostin levels to age, gender, or bone mass in humans. Thus we measured serum sclerostin levels in a population-based sample of 362 women [123 premenopau